Radiotherapy & Oncology
Volume 93, Issue 2 , Pages 220-225, November 2009

18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer

  • Hui Wang

      Affiliations

    • Service of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland
  • ,
  • Hansjörg Vees

      Affiliations

    • Service of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland
  • ,
  • Raymond Miralbell

      Affiliations

    • Service of Radiation Oncology, Geneva University Hospital, Geneva, Switzerland
  • ,
  • Michael Wissmeyer

      Affiliations

    • Service of Nuclear Medicine, Geneva University Hospital, Geneva, Switzerland
  • ,
  • Charles Steiner

      Affiliations

    • Service of Nuclear Medicine, Geneva University Hospital, Geneva, Switzerland
  • ,
  • Osman Ratib

      Affiliations

    • Service of Nuclear Medicine, Geneva University Hospital, Geneva, Switzerland
  • ,
  • Srinivasan Senthamizhchelvan

      Affiliations

    • Service of Nuclear Medicine, Geneva University Hospital, Geneva, Switzerland
  • ,
  • Habib Zaidi

      Affiliations

    • Service of Nuclear Medicine, Geneva University Hospital, Geneva, Switzerland
    • Geneva Neuroscience Center, Geneva University, Geneva, Switzerland
    • Corresponding Author InformationCorresponding author. Address: Division of Nuclear Medicine, Geneva University Hospital, CH-1211 Geneva 4, Switzerland.

Received 24 March 2009; received in revised form 25 August 2009; accepted 27 August 2009. published online 22 September 2009.

Abstract 

Background and purpose

We evaluate the contribution of 18F-choline PET/CT in the delineation of gross tumour volume (GTV) in local recurrent prostate cancer after initial irradiation using various PET image segmentation techniques.

Materials and methods

Seventeen patients with local-only recurrent prostate cancer (median=5.7years) after initial irradiation were included in the study. Rebiopsies were performed in 10 patients that confirmed the local recurrence. Following injection of 300MBq of 18F-fluorocholine, dynamic PET frames (3min each) were reconstructed from the list-mode acquisition. Five PET image segmentation techniques were used to delineate the 18F-choline-based GTVs. These included manual delineation of contours (GTVman) by two teams consisting of a radiation oncologist and a nuclear medicine physician each, a fixed threshold of 40% and 50% of the maximum signal intensity (GTV40% and GTV50%), signal-to-background ratio-based adaptive thresholding (GTVSBR), and a region growing (GTVRG) algorithm. Geographic mismatches between the GTVs were also assessed using overlap analysis.

Results

Inter-observer variability for manual delineation of GTVs was high but not statistically significant (p=0.459). In addition, the volumes and shapes of GTVs delineated using semi-automated techniques were significantly higher than those of GTVs defined manually.

Conclusions

Semi-automated segmentation techniques for 18F-choline PET-guided GTV delineation resulted in substantially higher GTVs compared to manual delineation and might replace the latter for determination of recurrent prostate cancer for partial prostate re-irradiation. The selection of the most appropriate segmentation algorithm still needs to be determined.

Keywords: PET/CT, 18F-fluorocholine, Image segmentation, Gross tumour volume, Recurrent prostate cancer

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(09)00471-X

doi:10.1016/j.radonc.2009.08.037

Radiotherapy & Oncology
Volume 93, Issue 2 , Pages 220-225, November 2009